Application Information

This drug has been submitted to the FDA under the reference 201281/001.

Names and composition

"JENTADUETO" is the commercial name of a drug composed of LINAGLIPTIN and METFORMIN HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
201281/001 JENTADUETO LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 2.5MG and 500MG
201281/002 JENTADUETO LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 2.5MG and 850MG
201281/003 JENTADUETO LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 2.5MG and 1GM

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
201281/001 JENTADUETO LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 2.5MG and 500MG
201281/002 JENTADUETO LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 2.5MG and 850MG
201281/003 JENTADUETO LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 2.5MG and 1GM
208026/001 JENTADUETO XR LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 2.5MG and 1GM
208026/002 JENTADUETO XR LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 5MG and 1GM

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved